ABOUT BREEGI SCIENTIFIC

Breegi Scientific Inc. (BSI) is an international Boston-based medical technology company founded in 2014. BSI is the recipient of several prestigious international grants and awards to develop the world's first portable, digital-native and low-cost infant incubator platform with a disposable housing: NICI™.

 

The Neonatal Intensive Care Incubator or NICI™ is the first multi-functional data-driven clinical platform of it's kind. It is a practical, user-friendly, efficient, low maintenance and cost-effective incubator designed to significantly reduce neonatal mortality and morbidity globally.

 

NICI™ fundamentally changes the century-old paradigm of neonatal incubators to be safer, more accessible and easier to manage. Together with a global team of experts across six continents, BSI has meticulously de-risked our clinical platform to be scaled for healthcare systems globally.

 

NICI™ is less than 1% of the cost, size and weight of standard hospital incubators while providing any community with critical NICU capabilities such as phototherapy, heat, humidity, oxygen support and clinical data to provide little ones with a healthy start.

 

BSI's long-term vision is a world where no babies die due to lack of access to neonatal incubators, and that biocontainment solutions should be safe, effective and accessible. Our second platform, the Negative Pressure SteriDome or NPS, emerged from our patented biocontainment platform at the start of the COVID-19 pandemic to protect frontline workers and received Emergency Use Authorization (EUA) from the FDA in May of 2021.